EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Enhanced Method for Transmitochondrial Cybrid Generation

Luke Weaver, Mikhail F Alexeyev iD

Cells · 14.05.2026 · 15 (10) · 898

DOI: 10.3390/cells15100898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 14.05.2026. Verfasst von Luke Weaver und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Cell Biology, University of South Alabama, Mobile, AL 36688, USA. Hauptthemen laut MEDLINE: Mitochondria, Hybrid Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Nationa Institutes of Health, Military Health System.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transmitochondrial cybrid technology is a key approach for elucidating the effects of mitochondrial DNA (mtDNA) mutations in defined nuclear genetic backgrounds and for studying nuclear–mitochondrial interactions. However, its application is limited by the availability of suitable recipient cell lines and by technically demanding enucleation procedures. We report three advances in cybrid technology: (1) enucleation using mitomycin C, a widely used agent for generating feeder layers in stem cell culture, which does not depend on cell attachment and provides a gentler alternative to actinomycin D; (2) selection of cybrids using mitochondrial uncouplers, which can reduce background survival of non-cybrid cells; and (3) cryopreservation of enucleated donor cells in liquid nitrogen, preserving fusion competence and increasing experimental flexibility. Additionally, we validate newly developed mtDNA-free (ρ0) derivatives of HCT116, HT1080, and U2OS cell lines as recipients for cybrid generation. These advances facilitated donor cell preparation, improved cybrid selection, and enhanced experimental flexibility, including the demonstration of preserved fusion competence of enucleated HeLa cells after 10 years of cryostorage. The ρ0 derivatives of HCT116, HT1080, and U2OS cells were confirmed as effective recipients. Together, these improvements enhance the efficiency and accessibility of transmitochondrial cybrid technology and are expected to facilitate its broader application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaHybrid CellsHumansDNA, MitochondrialMitomycinCryopreservationHeLa Cells

Stichwörter der Autor:innen

carbonyl cyanide m-chlorophenylhydrazonechemical enucleationmitochondrial DNAmitomycin Cniclosamide

Substanzen

DNA, MitochondrialMitomycin

Autor:innen und Institutionen

  • Department of Physiology and Cell Biology, University of South Alabama, Mobile, AL 36688, USA.
  • Department of Biomedical Sciences, University of South Alabama, Mobile, AL 36688, USA.

ORCID-Profile: Mikhail F Alexeyev

Förderung

  • NIH HHS
  • Nationa Institutes of Health
  • Military Health System
  • National Science Foundation
  • National institutes of Health
  • Office of the Assistant Secretary of Defense for Health Affairs

Zitieren

APA

Weaver, L., & Alexeyev, M. F. (2026). An Enhanced Method for Transmitochondrial Cybrid Generation. Cells, 15(10), 898. https://doi.org/10.3390/cells15100898

Vancouver

Weaver L, Alexeyev MF. An Enhanced Method for Transmitochondrial Cybrid Generation. Cells. 2026;15(10):898. doi:10.3390/cells15100898

BibTeX
@article{Weaver2026,
  author = {Weaver, Luke and Alexeyev, Mikhail F},
  title = {An Enhanced Method for Transmitochondrial Cybrid Generation},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {898},
  doi = {10.3390/cells15100898}
}
Kostenlos starten →